The earliest randomized studies of mRNA vaccines revealed several intriguing results, including an exponential rate of early infection following the first injection compared to placebo, reports The Epoch Times.
In a recent research paper from Sfera (Patton State Hospital, US) et al, the characterization of pathological syncytia or fusion between immune cells is described: âThe LNP technology, to put it simply, mimics viral envelopes with externalized phosphatidylserine (ePS), a universal âeat meâ signal, that directs immune cells to engulf the particle.
However, as ePS is also a potential âfuse meâ signal, LNP may inadvertently facilitate the formation of pathological syncytia. Moreover, ePS may activate a disintegrin and metalloprotease 10 and 17 (ADAM10) (ADAM 17), master regulators of syncytia formation, contributing further to the unintended consequence of cell-cell fusionâŠ